Latest News

Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease

October 9th 2024

Erik Musiek, MD, PhD, a professor of neurology at Washington University in St. Louis, provided clinical insight on a presentation from ANA 2024 highlighting the intricate relationship between circadian rhythms, glial activation, and neuroinflammation in Alzheimer disease.

NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria
NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria

October 9th 2024

5-Year Outcomes Add Supportive Evidence to Approved Gene Therapy for Duchenne
5-Year Outcomes Add Supportive Evidence to Approved Gene Therapy for Duchenne

October 8th 2024

Jose Soria, MD  (Credit: The Neuron Clinic)
Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

October 8th 2024

Ari Azhir, PhD  (Credit: LinkedIn)
Neuvivo Submits NDA to FDA for Investigational ALS Treatment NP001

October 8th 2024

Coverage of the 40th Congress of the European Committee for Treatment and Research in MS

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor in Copenhagen.

ECTRIMS 2024

Conference Coverage

View All
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease

October 9th 2024

NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria
NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria

October 9th 2024

Distinct Alzheimer Disease Subtypes Using Proteomic Fingerprints: Fiona Elwood, PhD
Distinct Alzheimer Disease Subtypes Using Proteomic Fingerprints: Fiona Elwood, PhD

October 8th 2024

Clinical Utility of Middle Meningeal Artery Embolization as an Adjunctive Treatment of Subdural Hematoma
Clinical Utility of Middle Meningeal Artery Embolization as an Adjunctive Treatment of Subdural Hematoma

October 7th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.